Long non-coding ribonucleic acid ATP2B1-AS1 modulates endothelial permeability through regulating the miR-4729-IQGAP2 axis in diabetic retinopathy

被引:7
作者
Ren, Zengjin
Wang, Xue [1 ]
机构
[1] Nanjing Med Univ, Kangda Coll, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China
关键词
Diabetic retinopathy; miR-4729; MECHANISMS;
D O I
10.1111/jdi.13740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Introduction Mounting evidence shows that long non-coding RNAs (lncRNAs) are important to modulate the biological process of diabetic retinopathy (DR). We aimed to investigate the role of lncRNAs in DR and elucidate the exact mechanism. Materials and Methods Real-time quantitative polymerase chain reaction was carried out to distinguish the lncRNA ATPase plasma membrane Ca2+ transporting 1 antisense RNA 1 (ATP2B1-AS1) expression in DR patients and HG-treated human retinal endothelial cells (HRECs). Dual-luciferase reporter system was used to verify that ATP2B1-AS1 could act as a microRNA (miR)-4729 sponge, and miR-4729 could bind to 3 ' UTR of IQ motif-containing GTPase-activating protein 2 (IQGAP2). Cell proliferation assay, wound healing migration assay, transwell assay, tube formation assay and immunofluorescence were used to investigate cell proliferation, migration and angiogenesis in HRECs. Results The present results showed that ATP2B1-AS1 was downregulated in DR patients and high-glucose-induced HRECs. In gain- and loss-of-function assays, ATP2B1-AS1 overexpression could significantly reduce cell proliferation, migration, angiogenesis and permeability induced by high glucose in vitro. Additionally, we carried out dual-luciferase reporter experiments to determine that ATP2B1-AS1 could act as a miR-4729 sponge. ATP2B1-AS1 overexpression could rescue miR-4729 mimics and short hairpin RNA-IQGAP2 induced cell proliferation, migration and angiogenesis in HRECs. Conclusions The present study showed that ATP2B1-AS1 acted as a miR-4729 sponge to regulate IQGAP2 reducing high-glucose-induced endothelial dysfunction in DR.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 30 条
  • [11] Ocular Drug Delivery: Present Innovations and Future Challenges
    Gote, Vrinda
    Sikder, Sadia
    Sicotte, Jeff
    Pal, Dhananjay
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (03) : 602 - 624
  • [12] Gotzaridis E V, 2001, Semin Ophthalmol, V16, P31
  • [13] The biology of IQGAP proteins: beyond the cytoskeleton
    Hedman, Andrew C.
    Smith, Jessica M.
    Sacks, David B.
    [J]. EMBO REPORTS, 2015, 16 (04) : 427 - 446
  • [14] Diabetic Retinopathy Screening and Registration in Europe-Narrative Review
    Hristova, Elitsa
    Koseva, Darina
    Zlatarova, Zornitsa
    Dokova, Klara
    [J]. HEALTHCARE, 2021, 9 (06)
  • [15] Should the word 'dementia' be forgotten?
    Jellinger, Kurt A.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (10) : 2415 - 2416
  • [16] Drug delivery to the eye: what benefits do nanocarriers offer?
    Joseph, Rini Rachel
    Venkatraman, Subbu S.
    [J]. NANOMEDICINE, 2017, 12 (06) : 683 - 702
  • [17] Characterization of In Vivo Retinal Lesions of Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy
    Karst, Sonja G.
    Lammer, Jan
    Radwan, Salma H.
    Kwak, Hanna
    Silva, Paolo S.
    Burns, Stephen A.
    Aiello, Lloyd Paul
    Sun, Jennifer K.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [18] Noncoding RNA Gas5 Is a Growth Arrest- and Starvation-Associated Repressor of the Glucocorticoid Receptor
    Kino, Tomoshige
    Hurt, Darrell E.
    Ichijo, Takamasa
    Nader, Nancy
    Chrousos, George P.
    [J]. SCIENCE SIGNALING, 2010, 3 (107) : ra8
  • [19] Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
    Lee, Ryan
    Wong, Tien Y.
    Sabanayagam, Charumathi
    [J]. EYE AND VISION, 2015, 2
  • [20] Role of interferons in diabetic retinopathy
    Li, Bing-Yan
    Tan, Wei
    Zou, Jing-Ling
    He, Yan
    Yoshida, Shigeo
    Jiang, Bing
    Zhou, Ye-Di
    [J]. WORLD JOURNAL OF DIABETES, 2021, 12 (07) : 939 - 953